Will the Paradigm share price climb higher on promising ASX update?

Lachlan Hall | May 8, 2019

Paradigm Biopharmaceuticals Ltd (ASX: PAR) shares could climb higher in early trade after a promising corporate update to the ASX this morning by the... More »

Top ASX stock picks for May

Motley Fool Staff | May 1, 2019

Costa Group Holdings Ltd (ASX: CGC), Bellamy’s Australia Limited (ASX: BAL) and Macquarie Group Ltd (ASX: MQG) are among the Foolish writers' top ASX... More »

Why Kogan, Northern Star, Paradigm, & Wagners shares tumbled lower today

James Mickleboro | April 24, 2019

The Kogan.com Ltd (ASX:KGN) share price and the Northern Star Resources Ltd (ASX:NST) share price are two of four tumbling notably lower on Wednesday.... More »

Where does the Paradigm Biopharmaceuticals share price go from here?

Elton Wang | April 23, 2019

Paradigm Biopharmaceuticals Ltd (ASX: PAR): buy, hold, sell? More »

Why this ASX300 healthcare share price is up 414% in the last year

Lachlan Hall | April 15, 2019

Paradigm Biopharmaceuticals Ltd (ASX: PAR) shares remain in a trading halt after announcing a capital raise to support the next phase of its osteoarthritis... More »

Over 610% higher in 12 months: The Paradigm share price still has plenty of growth ahead

Elton Wang | April 2, 2019

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has zoomed 610% higher in 12 months to near its all-time high. Here is why I... More »

Top ASX Stock Picks for April

Motley Fool Staff | April 1, 2019

Bellamy's Australia Ltd (ASX: BAL), Pilbara Minerals Limited (ASX: PSL) and Aristocrat Leisure Limited (ASX: ALL) shares are among the mixed bag of ASX... More »

These small cap ASX shares are surging higher today

James Mickleboro | December 18, 2018

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is one of three surging higher at the small end of the market on Tuesday. Here's why... More »

Why the Paradigm Biopharmaceuticals share price rocketed 63% higher today

James Mickleboro | December 18, 2018

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price rocketed as much as 63% higher this morning after announcing positive clinical trial results... More »

Is it too late to buy these market beating ASX shares?

James Mickleboro | December 11, 2018

The Saracen Mineral Holdings Limited (ASX:SAR) share price is one of three that hit a 52-week high despite the market selloff... More »

Why the Paradigm Biopharmaceuticals share price has surged 11% higher

Motley Fool Staff | December 7, 2018

Here's why the Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has surged 11% higher on Friday. More »

These 3 ASX small cap shares are ending the week on a high

James Mickleboro | December 7, 2018

The Jumbo Interactive Ltd (ASX:JIN) share price is one of three at the small end of the market ending the week on a high... More »

Why these 4 ASX shares are sinking lower today

James Mickleboro | November 28, 2018

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price is one of four sinking lower on the ASX on Wednesday. Here's what you need to know... More »

3 ASX shares at 52-week highs: Is it too late to invest?

James Mickleboro | November 27, 2018

The Technology One Limited (ASX:TNE) share price is one of three racing to a 52-week high on Tuesday. Is it too late to invest? More »